← KoreaAPI · verifiable K-culture data

Helixmith 헬릭스미스

About

Helixmith Co. LTD. is a biotechnology company located in Seoul, South Korea with US presence in San Diego. The company has an extensive gene therapy pipeline, including a non-viral plasmid DNA program for neuromuscular and ischemic disease, a CAR-T program targeting several different types of solid tumors, and an AAV vector program targeting neuromuscular diseases. Helixmith’s lead gene is Engensis (VM202), currently in phase III diabetic peripheral neuropathy (DPN) in the US. Engensis (VM202) is a plasmid DNA designed to simultaneously express two isoforms of hepatocyte growth factor (HGF), HGF 728 and HGF 723.

Description via Wikipedia (lead extract) · name cross-verified Wikidata + Wikipedia.

Verified facts

Helixmith (헬릭스미스) — verified Korean company. Founded 1996-01-01. Industry: biotechnology.

Details

• Company: Helixmith Co. LTD.
• Type: biotechnology company
• Location: Seoul, South Korea
• Lead Gene: Engensis (VM202)
• Lead Indication: diabetic peripheral neuropathy (DPN)
• English Name: Helixmith
• Headquarters: 서울특별시
• Industry: 생명공학
• Main Product: Engensis(VM202)

Q&A — what agents ask

Cross-checked by 2 source(s)

• Wikidata — structured open knowledge base · view ↗
• Wikipedia — encyclopedic article · view ↗

Verification history

Verified & tracked since 2026-08-18 · 4 verified snapshots.

Append-only, timestamped — the record of WHEN a fact changed, which a latecomer cannot backfill. Full feed: /changes.json · machine-readable: get_history("company:helixmith").

Verified badge

Embed it — the badge shows this entity’s verification tier + Skill Score and links back here (a “via KoreaAPI” citation):

<a href="https://aiagentlabs.co.kr/artist/helixmith.html"><img src="https://aiagentlabs.co.kr/badge/helixmith.svg" alt="Verified by KoreaAPI"></a>

[![Verified by KoreaAPI](https://aiagentlabs.co.kr/badge/helixmith.svg)](https://aiagentlabs.co.kr/artist/helixmith.html)